Last Updated : February 24, 2012
Details
FilesGeneric Name:
Rituximab
Project Status:
Complete
Therapeutic Area:
Granulomatosis with polyangiitis and microscopic polyangiitis
Manufacturer:
Hoffman-La Roche Ltd.
Call for patient/clinician input open:
Brand Name:
Rituxan
Project Line:
Reimbursement Review
Project Number:
SR0270-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA), remission induction (adults)
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : February 24, 2012